This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr Jens Kaufmann, PhD
Director Technical Operations at 3B Pharmaceuticals
Speaker

Profile

Dr. Jens Kaufmann is Director of Technical Operations at 3B Pharmaceuticals GmbH, bringing extensive expertise in supply chain management, radiochemistry, and radiopharmacy. He co-founded 1717 Life Science Ventures as well as PentixaPharm and serves as its Managing Director. Dr. Kaufmann's professional journey includes roles such as Director of Radiopharmaceutical Development at Ipsen Pharma, Head of Radiopharmaceutical Development at OctreoPharm Sciences, and heading Eckert & Ziegler’s Chemical Product and Process Development as well as the radiopharmaceutical contract manufacturing business. His academic background is rooted in chemistry, with a focus on radiochemistry of peptides and small molecules.

Agenda Sessions

  • Progress in the Development of Targeted Peptide Radiopharmaceuticals: Challenges, Successes and Case Studies

    8:30am